By Jeffrey Mark, M.D.
Medically reviewed by Frances Mark, Pharm.D.
You forget a name you have known for years. You walk into a room and cannot remember why you came. You reread the same paragraph because your concentration is not what it used to be.
Most people laugh it off as aging.
But if you have watched a parent lose independence to dementia, those little moments can carry a much heavier question: could this be the beginning?
Then another concern arises. Perhaps you take a statin to lower cholesterol and protect your heart, yet you have heard that statins can lower CoQ10 and affect mitochondrial function. Could something helping your cardiovascular system somehow be hurting your brain?
The honest answer about statins and memory is more complicated, and more reassuring, than internet headlines suggest.
Large human studies have not shown that long-term statin use causes dementia. In fact, several studies associate statin use with lower rates of dementia, likely in part because protecting blood vessels and preventing strokes also protects the brain.
But that does not mean every symptom should be ignored.
Statins affect the biochemical pathway involved in producing Coenzyme Q10, which participates in mitochondrial energy production. Some patients experience muscle pain, weakness, fatigue or exercise intolerance. Rare reversible cognitive complaints have also been reported.
The better question is not simply, “Are statins good or bad?” It is: what is happening to the entire system supporting your brain?
Statins and Memory: What the Large Studies Actually Show
Start with the largest picture available.
In 2020, researchers pooled 30 observational studies with more than 9.1 million participants. People taking statins had roughly 17 percent lower risk of all-cause dementia and lower risk of Alzheimer disease specifically; vascular dementia risk was not significantly changed either way. A separate dose-response analysis found that longer average use was associated with lower observed dementia risk, not higher.
Now the stronger evidence: a 2025 meta-analysis of randomized trials of lipid-lowering therapy, more than 139,000 participants in the dementia reporting trials, found cognitive impairment or dementia at almost identical rates with and without treatment. The takeaway across millions of real-world patients and 139,000-plus trial participants: no signal that statins steal memory.
One caution belongs beside that comfort: observational studies cannot fully separate the medication from the person taking it, because people who keep taking preventive medications are often healthier in other ways. The trials correct for that hopeful thinking.
Your Blood Vessels Feed Your Brain
Here is one reason the reassurance makes biological sense.
Specialist statements from the American Heart Association and American Stroke Association describe vascular contributions to cognitive impairment and dementia as common. When the small vessels of the heart struggle, the same process is often underway in the small vessels of the brain. High blood pressure, diabetes, abnormal cholesterol and smoking raise both risks. A stroke itself can leave lasting cognitive changes, so stroke prevention sits at the center of any brain-health strategy.
So when a study finds lower dementia risk among statin users, a real mechanism is at least plausible: better protected blood vessels are a better blood supply for the brain. That logic supports caring for the whole vascular picture, not just the cholesterol number.
Mitochondria: The Energy Story Behind the Worry
Your brain is one of the most energy-demanding organs you own: about two percent of your body weight, drawing roughly a fifth of the energy you burn at rest, mostly glucose. Its cells depend heavily on mitochondria, microscopic structures that produce the energy every thought uses. Mitochondrial dysfunction is increasingly recognized as an important feature of neurodegenerative disease.
But mitochondria are one piece of the puzzle, not the whole diagnosis.
Where CoQ10 comes in
Statins block an enzyme at the top of the mevalonate pathway. Downstream, that lowers cholesterol. It also lowers Coenzyme Q10: statins block the intermediate CoQ10 synthesis requires, and CoQ10 is one of the molecules mitochondria use to make energy. Statin treatment reliably lowers circulating CoQ10, although its effect on CoQ10 inside muscle cells is less clear.
That pathway echoes in the muscle data: a meta-analysis of 135 randomized trials found statins raised the risk of muscle symptoms versus placebo, a small but real increase. Some patients genuinely feel muscle pain, weakness, fatigue or exercise intolerance. Unexplained fatigue deserves a closer look in these situations, not a shrug; the same evaluate, do not endure instinct we apply to GLP-1 fatigue belongs here.
Rare, reversible cognitive reports
Now the honest edge of the story. Beyond the large data, there are rare reports of cognitive complaints linked to statins. A survey of 171 patients who self-reported memory problems while on statins found that most who stopped the medication reported improvement, sometimes within days, and a smaller group who restarted a statin reported problems again. Two published case reports describe cognitive deficits that reversed after stopping simvastatin.
Keep these in proportion: surveys cannot prove the medication caused the problem, and no large trial has shown statins cause dementia. But a symptom that appears near a medication change and lifts when it stops is exactly what your prescriber should hear about, not a reason to stop quietly on your own.
CoQ10: what the trials actually show
Should you add CoQ10? The trials disagree a little. An updated meta-analysis of 12 randomized trials in 575 patients found CoQ10 improved scores for muscle pain, weakness and cramps. A separate large meta-analysis found no significant benefit, and the newest review found a modest reduction in pain intensity and called for more research.
Mixed and modest is the honest summary, which is why CoQ10 is a conversation with your prescribing clinician and pharmacist, who can weigh dose, interactions and your other conditions, not a supplement to bolt onto a statin on your own.
Five Interlocking Areas for Cognitive Longevity
Insulin resistance matters. Blood pressure matters. Sleep matters. Muscle mass matters. Nutrient status matters. Gut health matters. Vascular health matters.
Many of these problems can be developing quietly for years before significant memory loss becomes obvious.
That is the part I wish more people understood. In my practice, I think about cognitive longevity through five interconnected areas: the gut, metabolism, mitochondria, vascular health and the brain itself.
The gut is where the story is least visible. Your intestinal tract communicates continuously with your brain through nerves, hormones, immune signaling and metabolites produced by the gut microbiome. Gut bacteria participate in producing and metabolizing compounds that influence inflammation, glucose regulation and vascular function. A 2026 systematic review found higher gut microbial diversity tracks with better sleep and better cognitive function. Research increasingly examines links between microbiome changes, intestinal barrier function and cognitive decline. This does not mean an unhealthy gut automatically causes Alzheimer disease. It means the brain does not age independently of the gut that feeds it. If bloating, gas or irregular bowels ride along with your memory concerns, that pattern deserves testing rather than tolerance: our SIBO breath test guide and our deeper review of poor gut health, memory loss and brain fog are good starting points.
Metabolism is where quiet damage accumulates. Insulin resistance, creeping blood sugar, fatty liver disease without a drop of alcohol, and shrinking muscle mass change the metabolic weather your brain lives in. We explain why fatty liver shows up without alcohol and why muscle, not the scale alone, drives results on a weight-loss plateau. Sleep sits beside them: untreated apnea and short, fragmented sleep strain both the heart and the brain.
Blood vessels we covered. And the brain itself: one that keeps learning, moving and connecting holds more reserve than one left alone.
Cognitive Longevity Is About Identity, Independence and Legacy
For most of us, the deepest fear is not simply forgetting where we put our keys.
It is losing the ability to drive, travel, manage our own finances, make our own decisions, recognize the people we love, or remain independent in our own homes.
Cognitive longevity is really about preserving identity, independence and legacy. They are the specific things a brain-health plan either protects or forfeits: your own signature on your own decisions, the family stories only you can tell, the seat you keep at the table you built.
What You Can Do Without Stopping Your Statin
So what should you do?
If you are over 50, have a family history of dementia, notice increasing brain fog, live with diabetes or insulin resistance, high blood pressure, sleep apnea, cardiovascular disease, unexplained fatigue, or simply feel that your mental sharpness has changed, do not wait for significant memory loss before asking questions.
And do not stop a statin or other prescribed medication on your own. Quietly stopping removes the protection your prescription provides and the information your symptoms were trying to give you. Severe muscle pain, weakness or dark urine needs urgent medical attention, not waiting.
Instead, ask your physician to look beyond a single cholesterol number and evaluate the broader factors influencing your long-term cognitive health: metabolic health, vascular risk, sleep, nutrient status, medication effects, muscle health, gut health and other modifiable contributors, while there is still time to influence them.
The most valuable cognitive-health appointment may be the one you make before you believe you need it.
Because protecting your brain is not simply about living longer. It is about remaining clear-minded, strong, independent and fully present for the people and purpose that make those additional years worth having.
How The Real Gut Doctor Helps
This is exactly the kind of evaluation The Real Gut Doctor was built for. Dr. Fran and I bring gastroenterology and clinical pharmacy under one roof, so a statin question gets both angles: the medication timeline, dose and interactions reviewed against your symptoms, and the five interlocking areas assessed as one system. We look at metabolic and vascular risk, sleep, nutrient status, muscle and body composition, and gut function, then give you a plain-language map of what is driving what, what is already protecting you, and what can realistically change.
Your future health deserves more than a wait-and-see approach. If you have been quietly carrying this worry, we would be honored to guide you through the process. You can book a discovery call with us and we will help you decide what to evaluate first, what to track, and how your medication plan fits, entirely alongside your prescribing physician.
FAQ
Do statins cause dementia?
Large human data point the other way: randomized trials showed no excess of cognitive impairment or dementia, and a 9.1-million-participant observational analysis found lower dementia risk among statin users, reflecting both healthier-user patterns and genuine vascular protection. Statins have not been shown to cause dementia.
Can statins cause temporary memory problems?
Rare, reversible cognitive complaints have been reported, mostly in case reports and patient surveys, and some resolved after the statin stopped. This is not a proven class effect, but a memory change that began soon after an adjustment belongs in the conversation with your prescriber. Never stop the medication on your own; report it instead.
Should I take CoQ10 with my statin?
Discuss it first. The mechanism is real: statins lower the pathway that produces CoQ10. The supplement trials are mixed, with some showing modest improvement in muscle symptoms and others none, so routine supplementation is not recommended. Treat it as a shared decision with your prescriber and pharmacist, not a self-prescribed add-on.
Why do I feel forgetful if my statin is innocent?
Because memory runs on systems, and several can drain it. Short or poor-quality sleep, untreated sleep apnea, thyroid problems, low B12, blood sugar swings, other medications and chronic stress all pull on the same thread. That is why a broad evaluation beats a single test or a single suspect.
When should memory worries get an early evaluation?
Before symptoms are severe. Family history of dementia, cardiovascular or metabolic disease, persistent brain fog, new fatigue, or a felt change in sharpness are all reasonable triggers in your 50s and beyond. The most valuable visit is the one made while function is intact and modifiable factors still have time to respond.
References
- Poly TN, et al. Association between Use of Statin and Risk of Dementia: A Meta-Analysis of Observational Studies. Neuroepidemiology. 2020.
- Reddin C, et al. Association of lipid-lowering therapy with dementia and cognitive outcomes: a systematic review and meta-analysis. Age Ageing. 2025.
- Zhang X, Wen J, Zhang Z. Statins use and risk of dementia: A dose-response meta analysis. Medicine (Baltimore). 2018.
- Gorelick PB, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011.
- Mergenthaler P, et al. Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci. 2013.
- Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell. 2012.
- Klemmensen MM, et al. Mitochondrial dysfunction in neurodegenerative disorders. Neurotherapeutics. 2024.
- Marcoff L, Thompson PD. The role of coenzyme Q10 in statin-associated myopathy: a systematic review. J Am Coll Cardiol. 2007.
- Irwin JC, et al. The effect of lipophilicity and dose on the frequency of statin-associated muscle symptoms: A systematic review and meta-analysis. Pharmacol Res. 2018.
- Qu H, et al. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2018.
- Banach M, et al. Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. Mayo Clin Proc. 2015.
- Evans MA, Golomb BA. Statin-associated adverse cognitive effects: survey results from 171 patients. Pharmacotherapy. 2009.
- Suraweera C, et al. Simvastatin-induced cognitive dysfunction: two case reports. J Med Case Rep. 2016.
- Varpaei HA, et al. Gut microbiota, sleep quality, and cognitive function in adults: A systematic review. Sleep Med. 2026.
Medical disclaimer
This article is for education only and does not replace personalized medical diagnosis or treatment. Statin decisions, doses, CoQ10 use, and heart and brain evaluations should always be individualized by a qualified clinician who knows your history and current health. Never stop or start a prescribed medication without your prescribing clinician. If you develop severe muscle pain, weakness, or dark urine, seek urgent medical evaluation. Individual results may vary.
